MedPath

Effect of caffeine in premature infants

Phase 2
Conditions
Osteopenia of prematurity.
Other specified disorders of bone density and structure, other site
M85. 88
Registration Number
IRCT20230914059430N2
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
38
Inclusion Criteria

Infants with a fetal age of less than 32 weeks
Infants who had spontaneous breathing

Exclusion Criteria

Neonates with major congenital anomalies
Asphyxiation
Hypoxic Ischemic Encephalopathy stage 2 , 3
Intrauterine growth retardation
Neonates with cholestasis
Neonates with neuromuscular disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum levels of calcium. Timepoint: Serum levels of calcium was evaluated at two weeks and also at the time of discharge. Method of measurement: The records of patients.;Serum levels of phosphors. Timepoint: Serum levels of phosphor was evaluated at two weeks and also at the time of discharge. Method of measurement: The records of patients.;Serum levels of alkaline phosphatase. Timepoint: Serum levels of alkaline phosphatase was evaluated at two weeks and also at the time of discharge. Method of measurement: The records of patients.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath